迈瑞医疗：2025年前三季度国际业务占公司整体收入的比重已经超过了一半

Core Viewpoint - Mindray Medical anticipates that by the first three quarters of 2025, international business will account for over half of the company's total revenue, with a continuous increase expected in the coming years [1] Group 1: International Business Growth - The company is focusing on localized platform development, which is expected to enhance the proportion of international revenue in overall income [1] - Developing countries are projected to maintain a rapid growth trend in terms of international revenue [1] Group 2: Profitability and Client Structure - The proportion of high-end clients within the revenue structure is expected to continue increasing, which may lead to a steady improvement in the profitability of international business [1] - Detailed financial information will be available in the annual report scheduled for release on March 31, 2026 [1]